NDC | 68071-3063-2, 68071-3063-3, 68071-3063-6, 68071-3063-9 |
Set ID | 4a64c7f3-b304-4e5e-e054-00144ff8d46c |
Category | HUMAN OTC DRUG LABEL |
Packager | NuCare Pharmaceuticals, Inc. |
Generic Name | |
Product Class | Antiemetic |
Product Number | |
Application Number | PART336 |
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
- PURPOSE
- INDICATIONS & USAGE
-
WARNINGS
Warnings
Ask a doctor before use if you have
- glaucoma
- a breathing problem such as emphysema or chronic bronchitis
- trouble urinating due to an enlarged prostate gland
- DOSAGE & ADMINISTRATION
- STORAGE AND HANDLING
- INACTIVE INGREDIENT
- QUESTIONS
- OTHER SAFETY INFORMATION
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
RUGBY MECLIZINE HCL, 12.5 MG EACH ANTIEMETIC
meclizine hcl tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68071-3063(NDC:0536-1017) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE 12.5 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM SULFATE (UNII: 0YPR65R21J) STEARIC ACID (UNII: 4ELV7Z65AP) Product Characteristics Color white Score 2 pieces Shape CAPSULE (modified capsule shaped uncoated tablet with bisect) Size 3mm Flavor Imprint Code 19G Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68071-3063-2 20 in 1 BOTTLE; Type 0: Not a Combination Product 03/10/2017 2 NDC:68071-3063-3 30 in 1 BOTTLE; Type 0: Not a Combination Product 03/10/2017 3 NDC:68071-3063-6 60 in 1 BOTTLE; Type 0: Not a Combination Product 03/10/2017 4 NDC:68071-3063-9 90 in 1 BOTTLE; Type 0: Not a Combination Product 03/10/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part336 03/07/2014 Labeler - NuCare Pharmaceuticals, Inc. (010632300) Establishment Name Address ID/FEI Business Operations NuCare Pharmaceuticals, Inc. 010632300 repack(68071-3063)